Clinical trials
Terminated Phase 3 trials in Iran
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rajaie Cardiovascular Medical and Research Center | 2 |
| Shahid Beheshti University of Medical Sciences | 1 |
| Tehran University of Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 1 |
| Gangliosidoses, GM2 | 1 |
| Mitral Valve Stenosis | 1 |
| Pulmonary Embolism | 1 |
| Rheumatic Heart Disease | 1 |
| Sandhoff Disease | 1 |
| Tay-Sachs Disease | 1 |
| Urinary Tract Infections | 1 |
| Ventricular Dysfunction, Right | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.